|
1 |
Finne U et al. |
Effects of mixing on timolol release from matrices of isopropyl PVM-MA with and without a basic additive.
|
|
2 |
Finne U et al. |
Timolol release from matrices of monoesters of poly(vinyl methyl ether/maleic anhydride). The effects of polymer molecular weigt and a basic additive.
|
|
3 |
Finne U et al. |
Sodium acetate improves the ocular/systemic absorption ratio of timolol applied oculary in monoisopropyl PVM-MA matrices.
|
|
4 |
Finne U et al. |
In vitro/in vivo comparison of timolol maleate release from buffered and unbuffered matrices of monoisopropyl ester of poly(vinyl methyl ether/maleic anhydride).
|
|
5 |
Hirvonen J et al. |
Reversible enhancement of transdermal propranolol by dodecyl N,N-dimethyl amino acetate.
|
|
6 |
Hirvonen J et al. |
Dodecyl N,N-dimethylamino acetate and Azone enhance drug penetration across human, snake and rabbit skin.
|
|
7 |
Ilkka J, Paronen P. |
Predictability of compression behaviour of powder mixtures using the Heckel treatment.
|
|
8 |
Järvinen T et al. |
Synthesis and identification of pilocarpic acid diesters, prodrugs of pilocarpine.
|
|
9 |
Järvinen T et al. |
O,O'-(1,4-Xylylene) bispilocarpic acid esters as new potential double prodrugs of pilocarpine for improved ocular delivery. I. Synthesis and analysis.
|
|
10 |
Järvinen T et al. |
O,O'-(1,4-Xylylene) bispilocarpic acid esters as new potential double prodrugs of pilocarpine for improved ocular delivery. II. Physicochemical properties, stability, solubility and enzymatic hydrolysis.
|
|
11 |
Pesonen T. |
Material and direct compression properties of an agglomerated cellulose powder.
|
|
12 |
Saano V et al. |
Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers.
|
|
13 |
Suhonen P et al. |
Permeability of pilocarpic acid diesters across albino rabbit cornea in vitro.
|
|
14 |
Suhonen P et al. |
Function of epithelia as a site of hydrolysis during corneal penetration of lipophilic pilocarpine prodrugs.
|
|
15 |
Suhonen P et al. |
Improved corneal pilocarpine permeability with O,O'-(1,4-Xylylene) bispilocarpic acid ester double prodrugs.
|
|
16 |
Urtti A. |
Silmälääkinnän kehitysnäkymistä.
|
|
17 |
Urtti A. |
Simulation of the absorptive membrane permeability effects on in vivo drug release from controlled release systems.
|
|
18 |
Vidgren M et al. |
Deposition and gastrointestinal transit of a conventional sucralfate tablet.
|
|
19 |
Vidgren M et al. |
Deposition and transition of sucralfate after administration from conventional and affervescent tablets.
|
|
20 |
Vidgren M et al. |
Dissolution and pharmacokinetic profiles of conventional and effervescent tablets and soft gelatin capsules containing ibuprofen.
|
|
21 |
Vidgren M et al. |
In vitro dissolution and pharmacokinetic evaluation of two filmcoated and an effervescent tablet of ibuprofen.
|
|
22 |
Vidgren M et al. |
Physical properties and clinical efficacy of two sodium cromoglycate inhalation aerosol preparations.
|
|
23 |
Vidgren P et al. |
In vitro inhalation behaviour and therapeutical response of salbutamol particles administered from two metered dose aerosols.
|
|
24 |
Vidgren P et al. |
Preparation and in vitro evaluation of disodium cromoglycate microspheres for nasal administration.
|
|
25 |
Vidgren P et al. |
In vitro deposition and clinical efficacy of two disodium cromoglycate inhalation powders.
|
|
26 |
Vidgren P et al. |
Removal of the inhaled 99mTc-labelled particles of disodium cromoglycate from the lungs.
|
|
27 |
Vidgren P et al. |
In vitro and in vivo evaluation of nasal mucoadhesion of disodium cromoglycate microspheres.
|
|
28 |
Vidgren P et al. |
Double-labelling technique in the evaluation of disodium cromoglycate microspheres.
|